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EARLY VERSUS DELAYED SURGERY IN
GALLSTONE PANCREATITIS
ABSTRACT
T.R. Kelly, D.S. Wagner. (1988) Gallstone pancreatitis: a prospective randomized trial
of the timing ofsurgery. Surgery, 104, 600-605.
The correct timing of surgery in cases of gallstone pancreatitis is debatable. To delineate
more clearly the influence of the timing of surgery in the treatment of the disease, a
prospective randomized clinical study ofearly surgery (less than 48 hours after admission)
and delayed surgery (more than 48 hours after admission) was conducted in 165 patients.
Ranson’s prognostic signs ofseverity of disease were used to classify the patients into two
risk groups: mild pancreatitis (three or fewer positive signs) and severe pancreatitis (more
than three positive signs). In patients with three or fewer positive Ranson’s signs, the time
of surgery appeared to have little effect on the outcome, whereas in patients with more
than three positive signs, early surgery resulted in a significant increase in rates of
morbidity and mortality. Controlled randomization showed that in patients with gallstone
pancreatitis, edematous or hemorrhagic necrotizing pancreatitis can develop, with or
without inpacted stones, early or late in the progression of the disease, during early or
delayed surgery. These findings suggest that (1) although a gallstone initiates a bout of
pancreatitis, it does not cause the progression ofthe disease; (2) the fate ofthe progression
of pancreatitis is decided early by the amount of digestive enzymes being activated; (3)
early removal of an impacted stone does not ameliorate th.e progression )f pancreatitis;
and (4) surgery should be performed during the initial hospital admission after the
pancreatitis has subsided.
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PAPER DISCUSSION
The timing of interventional therapies in the management of gallstone pancreatitis
continues to be a much debated issue. Studies addressing the timing of surgery have
been seriously hampered by small numbers of patients presenting with a disease of
widely varying clinical severity. The broad spectrum of this disease has lead to a wide
variety of management styles to which proponents of each attribute success.
Prospective trials with large numbers ofpatients, such as that ofKelly and Wagner, are
needed to sort through this increasingly complex range of management
recommendations. They have partially addressed the crucial issue of widely varying
clinical severity by stratifying patients by Ranson’s criteria.
Previous studies have not been as convincing regarding recommendations for the
timing of surgery, for a variety of reasons including the lack of severity stratification.
Ranson presented data from a retrospective non-randomized study in the late 1970s
which tended to show benefit ofdelayed operation in the most severe cases ofgallstone
pancreatitis 1. His definition of early surgery (within one week of admission) was
however fairly generous and patients were not randomized to any particular treatment
protocol. Most retrospective studies have agreed with his conclusions24. They have
suggested that most patients pass the gallstone and clinically improve without the need
for surgery. In patients with mild disease, all studies have shown that the timing of
surgery is not important. However, these retrospective studies have shown that, with
sick patients, early surgery seems to be associated with high risk. Whether the high
mortality and morbidity of this group was a direct result of surgery or represented a
selection bias toward intervention in the sickest patients, was not clear.
In contrast to most reports, Stone’s group found no adverse effects of early
operation in a prospective randomized trial s. They randomized a group of 65 patients
to operation within 73 hours of admission or to conservative management with
eventual operation three months after the acute admission. Their operative procedure
represented one of the most aggressive recommendations cholecystectomy,
transduodenal sphincteroplasty, and pancreatic duct septostomy. A major flaw in this
study, however, is the lack of stratification by clinical severity ofdisease, since previous
studies showed that most patients have mild disease and would get better with
expectant management only. Most studies, such as that ofKelly and Wagner, place the
incidence ofsevere cases (as defined by greater than three Ranson’s criteria) to be in the
range of25%. The numbers ofpatients in Stone’s study, 36 in the early operation group
and 29 in the late group, are so small that the impact of any such aggressive
intervention on the morbidity and mortality ofthe high-risk patients cannot be clearly
or statistically evaluated with any reasonable degree of certainty. Further, some of the
poor outcomes in the late operation group might be blamed on the unusually long
delay past the resolution of acute symptoms before cholecystectomy. This study leaves
unanswered the role of surgery in the sickest patients while further confirming the
previous observation that the timing of surgery is unimportant to the vast majority of
low-risk patients.
Kelly presents an elegant and larger prospective trial where patients were
randomized to operation within 48 hours of admission or after 48 hours. Further, the
patients were stratified for severity by Ranson’s criteria. The previous suspected
relationship of early surgery with increased morbidity and mortality for the patients
with the most severe pancreatitis was proven. The morbidity of those patients with
greater than three Ranson’s criteria was 19/23, or 83%, for early operation as
compared to 3/17, or 18%, for late operation. Further, the mortality statistics are even
more striking with 11/23, or 48%, mortality in the early group compared to 2/17, orHPB INTERNATIONAL 365
11%, mortality in the late operation group. This study used the more conventional
operative techniques of cholecystectomy and operative cholangiogram with common
bile duct exploration and sphincteroplasty being reserved only for those patients with
positive cholangiography. Although this study dissuades from early intervention in the
severe cases, it must be pointed out that Stone’s study did take a more aggressive tack
with the inclusion ofoperative sphincteroplasty in all cases. It is interesting to note that
the natural urge for intervention in severe cases led to the use ofERCP in eight patients
and papillotomy in one of Kelly’s late operation group. Although the claim is made
that an obstructing gallstone does not worsen the disease and that removal of that
obstructing stone does not ameliorate the progression of the disease, there is no clear-
cut data from this study to prove these points. The fact that patients did worse in the
early operation group may reflect only that this group of seriously ill patients can
tolerate less well the insults of surgery and anesthesia and their associated profound
changes in metabolism, irnmunity, etc. What is clear from this study is that surgical
intervention without papillotomy should be delayed, and delayed probably to the
point that symptoms have subsided.
ERCP and endoscopic papillotomy are other possible options in the management of
gallstone pancreatitis. Safrany and Cotton suggested this therapy with a small and
optimistic series in 19806 Since that time, several studies have looked at endoscopic
management with findings of routinely low mortality and morbidity7-9. Neoptolemos
and associates performed a prospective randomized trial ofERCP with papillotomy
versus conventional expectant mangement with stratification of patients by the
Glasgow criteria1 o. They had only twenty patients who were classified as severe. In that
group, 12 were managed conventionally and 8 with urgent ERCP/ES. Complications
occurred in 5/12 conventional and 2/8 ERCP patients and the only deaths were two in
the conventionally managed group. These results, when combined with other larger
retrospective European series, show clearly that this technique can be safely used in the
sickest patients7-9’ 11. It is possible that this therapy when performed early will reduce
the incidence of the most severe complications and deaths in those patients with the
worst prognosis as judged by the Glasgow criteria. This cannot be said conclusively,
however, without more patients and a larger trial. This method of management has
become popular in Europe because of its apparent safety.
The real unanswered question is whether or not early relief of ductal obstruction in
the sickest patients can change the natural history of their disease and reduce their
morbidity and mortality. Experimental studies seem to indicate that once the initial
injury has occurred, nothing alters the course ofthe disease12. Stone and Neoptolemos
have both concluded that early reliefofthis ductal obstruction will change the course of
the most severe forms ofgallstone pancreatitis. Although not clearly proven from their
data, this is a point which deserves further investigation. Since early surgical
intervention is associated with high risks by most groups and endoscopic intervention
associated with low risks, the optimal study would be to randomize the sickest patients
(> 3 Ranson’s criteria) to early endoscopic intervention versus conventional man-
agement with delayed surgery in a large multi-center prospective trial. A study such as
this might answer our lingering question concerning persistent ductal obstruction and
its relationship to clinical outcome for the most severe forms of gallstone pancreatitis.
William C. Dooley, M.D.
John L. Cameron, M.D.
Department of Surgery
The Johns Hopkins Hospital
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LIVERTRANSPLANTATION INTHETREATMENTOF
BLEEDING OESOPHAGEAL VARICES
ABSTRACT
S. lwatsuki, T.E. Starzl, S. Todo, R.D. Gordon, A.G. Tzakis, J. W. Marsh, L. Makowka,
B. Koneru, A. Stieber, G. Klintmalm, B. Husberg, D. van Thiel. (1988) Liver
transplantation in the treatment ofbleeding esophageal varices. Surgery, 104; 697-705.
From March 1980 to July 1987, 1000 patients with various end-stage liver diseases
received orthotopic liver transplants. Ofthe 1000 patients, three hundred two had definite
histories of bleeding from esophageal varices before transplantation. There were 287
patients with nonalcoholic liver diseases and 15 patients with alcoholic cirrhosis. All
patients had very poor liver function, which was the main indication for liver
transplantation. One- through 5-year actuarial survival rates of the 302 patients were
79%, 74%, 71%, 71%, and 71%, respectively. These survival rates are far better than
those obtained with other available modes of treatment for bleeding varices when liver
disease is advanced. Long-term sclerotherapy is the treatment of primary choice for
bleeding varices. Patients in whom sclerotherapy fails should be considered for liver
transplantation unless clear contraindications exist.
KEYWORDS: Liver
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